PMD实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally...

Stats
今日成交量	642.00
平均成交量	8 930.00
市值	14.80M
EPS	$0 ( 2024-03-21 )
下一个收益日期	( $0 ) 2024-05-07
Last Dividend	$0.0700 ( 2023-05-24 )
Next Dividend	$0 ( N/A )
P/E	-3.54
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-22	Mehalik Daniella	Buy	70 000	Stock Option (Right to Buy)
2024-01-22	Mehalik Daniella	Buy	35 000	Stock Option (Right to Buy)
2023-11-27	Mehalik Daniella	Sell	0	Common Stock, $.005 Par Value
2023-09-21	Shoemaker Shannon	Buy	80 000	Stock Option (Right to Buy)
2023-09-21	Shoemaker Shannon	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
94.08
Last 96 transactions
Buy: 1 000 549 \| Sell: 33 710

Psychemedics Corp 相关性

10 最正相关
HALL	0.894
GSM	0.876
ALTA	0.873
NEXI	0.862
OSMT	0.861
MRUS	0.86
XPER	0.855
SNCR	0.848
PAYO	0.847
SRZN	0.844

10 最负相关
CLDX	-0.902
BNIXU	-0.901
BLZE	-0.881
NUTX	-0.878
RDVT	-0.872
GLMD	-0.844
STIM	-0.843
BGNE	-0.843
COFS	-0.842
HALO	-0.842

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Psychemedics Corp 财务报表

Annual	2023
营收:	$22.10M
毛利润:	$8.41M (38.07 %)
EPS:	$-0.720

FY	2023
营收:	$22.10M
毛利润:	$8.41M (38.07 %)
EPS:	$-0.720

FY	2022
营收:	$25.24M
毛利润:	$9.29M (36.81 %)
EPS:	$-0.190

FY	2021
营收:	$24.91M
毛利润:	$10.26M (41.21 %)
EPS:	$-0.119

Financial Reports:

No articles found.

Psychemedics Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0700 (N/A)	$0.0700 (N/A)	$0.0700 (N/A)	$0.0700 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Psychemedics Corp Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.34 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0800	1997-01-13
Last Dividend	$0.0700	2023-05-24
Next Dividend	$0	N/A
Payout Date	2023-06-08
Next Payout Date	N/A
# dividends	100	--
Total Paid Out	$12.60	--
Avg. Dividend % Per Year	1.61%	--
Score	2.88	--
Div. Sustainability Score	2.34
Div.Growth Potential Score	0
Div. Directional Score	0.792	--

Next Divdend (Est)
(2024-07-04)

$0.0689 Estimate 9.67 %

Dividend Stability

0.39 Poor

Dividend Score

2.88

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
1997	$0.400	1.67%
1998	$0.440	1.87%
1999	$0.640	3.20%
2000	$0.640	3.56%
2001	$0.400	2.00%
2002	$0.240	1.46%
2003	$0.320	3.43%
2004	$0.320	3.37%
2005	$0.360	2.82%
2006	$0.475	3.39%
2007	$0.575	2.99%
2008	$0.660	4.13%
2009	$0.580	9.01%
2010	$0.480	6.08%
2011	$0.480	5.66%
2012	$0.600	6.49%
2013	$0.600	5.52%
2014	$0.600	4.14%
2015	$0.600	3.98%
2016	$0.600	6.17%
2017	$0.600	2.50%
2018	$0.690	3.33%
2019	$0.720	4.46%
2020	$0.180	2.00%
2021	$0.0500	0.97%
2022	$0.210	2.94%
2023	$0.140	2.84%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.188	1.500	-3.76	-5.64	[0 - 0.5]
returnOnAssetsTTM	-0.313	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.498	1.500	-6.64	-9.96	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.445	0.800	7.77	6.22	[1 - 3]
quickRatioTTM	1.204	0.800	7.62	6.10	[0.8 - 2.5]
cashRatioTTM	0.417	1.500	8.79	10.00	[0.2 - 2]
debtRatioTTM	0.173	-1.500	7.11	-10.00	[0 - 0.6]
interestCoverageTTM	4.22	1.000	9.55	9.55	[3 - 30]
operatingCashFlowPerShareTTM	-0.255	2.00	-0.0850	-0.170	[0 - 30]
freeCashFlowPerShareTTM	-0.277	2.00	-0.138	-0.277	[0 - 20]
debtEquityRatioTTM	0.344	-1.500	8.62	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.381	1.000	6.99	6.99	[0.2 - 0.8]
operatingProfitMarginTTM	-0.132	1.000	-4.64	-4.64	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.644	1.000	-4.69	-4.69	[0.2 - 2]
assetTurnoverTTM	1.665	0.800	2.23	1.785	[0.5 - 2]
Total Score				2.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-3.56	1.000	-0.461	0	[1 - 100]
returnOnEquityTTM	-0.498	2.50	-4.27	-9.96	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.277	2.00	-0.0923	-0.277	[0 - 30]
dividendYielPercentageTTM	2.75	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.255	2.00	-0.0850	-0.170	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.239	1.500	-1.741	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0670	1.000	-4.17	0	[0.1 - 0.5]
Total Score				-0.760

Psychemedics Corp

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.